Author Correction: WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 Sep 2019
Historique:
entrez: 11 9 2019
pubmed: 11 9 2019
medline: 11 9 2019
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41467-019-12060-5 PMID: 31501434 PMC: PMC6733793
pubmed: 31501434
doi: 10.1038/s41467-019-12060-5
pii: 10.1038/s41467-019-12060-5
pmc: PMC6733793
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

4085

Subventions

Organisme : Medical Research Council
ID : MC_U120085815
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/5/31446
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Huimei Chen (H)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Aida Moreno-Moral (A)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.
ORCID: 0000-0002-8155-3146

Francesco Pesce (F)

Department of Emergency and Organ Transplantation (DETO), University of Bari, 70124, Bari, Italy.

Nithya Devapragash (N)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Massimiliano Mancini (M)

SOC di Anatomia Patologica, Ospedale San Giovanni di Dio, 50123, Florence, Italy.

Ee Ling Heng (EL)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.

Maxime Rotival (M)

Unit of Human Evolutionary Genetics, Institute Pasteur, 75015, Paris, France.

Prashant K Srivastava (PK)

Division of Brain Sciences, Imperial College Faculty of Medicine, London, W12 0NN, UK.

Nathan Harmston (N)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Kirill Shkura (K)

Division of Brain Sciences, Imperial College Faculty of Medicine, London, W12 0NN, UK.

Owen J L Rackham (OJL)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Wei-Ping Yu (WP)

Animal Gene Editing Laboratory, BRC, A*STAR20 Biopolis Way, Singapore, 138668, Republic of Singapore.
Institute of Molecular and Cell Biology, A*STAR, 61 Biopolis Drive, Singapore, 138673, Republic of Singapore.

Xi-Ming Sun (XM)

MRC London Institute of Medical Sciences (LMC), Imperial College, London, W12 0NN, UK.

Nicole Gui Zhen Tee (NGZ)

National Heart Centre Singapore, Singapore, 169609, Republic of Singapore.

Elisabeth Li Sa Tan (ELS)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Paul J R Barton (PJR)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Trust, London, SW3 6NP, UK.
ORCID: 0000-0002-1165-7767

Leanne E Felkin (LE)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Trust, London, SW3 6NP, UK.

Enrique Lara-Pezzi (E)

Centro Nacional de Investigaciones Cardiovasculares - CNIC, 28029, Madrid, Spain.

Gianni Angelini (G)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Bristol Heart Institute, Bristol Medical School, University of Bristol, Bristol, BS2 89HW, UK.

Cristina Beltrami (C)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.

Michal Pravenec (M)

Institute of Physiology, Czech Academy of Sciences, 142 00, Praha 4, Czech Republic.

Sebastian Schafer (S)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.
National Heart Centre Singapore, Singapore, 169609, Republic of Singapore.
ORCID: 0000-0002-6909-8275

Leonardo Bottolo (L)

Department of Medical Genetics, University of Cambridge, Cambridge, CB2 0QQ, UK.
The Alan Turing Institute, London, NW1 2DB, UK.
MRC Biostatistics Unit, University of Cambridge, Cambridge, CB2 0SR, UK.
ORCID: 0000-0002-6381-2327

Norbert Hubner (N)

Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 13347, Berlin, Germany.
Charité-Universitätsmedizin, 10117, Berlin, Germany.
Berlin Institute of Health (BIH), 10178, Berlin, Germany.

Costanza Emanueli (C)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Trust, London, SW3 6NP, UK.

Stuart A Cook (SA)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.
MRC London Institute of Medical Sciences (LMC), Imperial College, London, W12 0NN, UK.
National Heart Centre Singapore, Singapore, 169609, Republic of Singapore.
ORCID: 0000-0001-6628-194X

Enrico Petretto (E)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore. enrico.petretto@duke-nus.edu.sg.
MRC London Institute of Medical Sciences (LMC), Imperial College, London, W12 0NN, UK. enrico.petretto@duke-nus.edu.sg.
ORCID: 0000-0003-2163-5921

Classifications MeSH